Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print March 20, 2008
DOI: 10.2337/db07-1217

This Article
Right arrow Full Text (PDF)
Right arrow Figures
Right arrow All Versions of this Article:
db07-1217v1
db07-1217v2
57/5/1387    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gubitosi-Klug, R. A.
Right arrow Articles by Kern, T. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gubitosi-Klug, R. A.
Right arrow Articles by Kern, T. S.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

5-Lipoxygenase, but not 12/15-Lipoxygenase, Contributes to Degeneration of Retinal Capillaries in a Mouse Model of Diabetic Retinopathy

Rose A. Gubitosi-Klug, M.D., Ph.D.1, Ramaprasad Talahalli, Ph.D.1, Yunpeng Du, Ph.D.2, Jerry L. Nadler, M.D.3, and Timothy S. Kern, Ph.D.2,,4

Department of Pediatrics, Case Western Reserve University/Rainbow Babies and Children's Hospital, Cleveland, OH1
Department of Medicine, Case Western Reserve University, Cleveland, OH2
Department of Internal Medicine, University of Virginia3; and
Veterans Administration Medical Center Research Service 151, Cleveland, OH4

Objective: Lipoxygenases are regulators of chronic inflammation and oxidative stress generation. We evaluated the role of 5- and 12-lipoxygenases in the development of diabetic retinopathy.

Research design and methods: Wild-type (WT) mice, 5-lipoxygenase-deficient (5-LO) mice, and 12/15-lipoxygenase-deficient (12-LO) mice were assessed 1) after 9 months of diabetes for retinal histopathology and leukotriene receptor expression, and 2) after 3 months of diabetes for leukostasis and retinal superoxide generation.

Results: Diabetic WT mice developed the expected degeneration of retinal capillaries and pericytes, and increases in both leukostasis and superoxide production (P<0.006). We found no evidence of diabetes-induced degeneration of retinal ganglion cells in these animals. The vascular histopathology was significantly inhibited in 5-LO-deficient mice, but not in 12-LO-deficient mice. Retinas from diabetic 5-LO deficient mice also had significantly less leukostasis, superoxide production and NF-kappaB expression (all p<0.006), whereas retinas from diabetic 12-LO-deficient mice had significantly less leukostasis (P<0.005) but not superoxide production or NF-kappaB expression. Retinas from diabetic wt mice were enriched with receptors for the 5-lo metabolite leukotriene b4.

Conclusions: Diabetes-induced histological and biochemical alterations were significantly reduced in 5-LO-deficient mice, but not 12-LO-deficient mice. 5-LO represents a novel pathway for therapeutic intervention of diabetic retinopathy.


Correspondence: Rose.Gubitosi-Klug{at}case.edu


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.